Brown Brothers Harriman & Co’s Genprex GNPX Stock Holding History

Brown Brothers Harriman & Co’s Portfolio GNPX Stock Details GNPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2	Closed	-$4.71K	–	1441
2024 Q2	$4.71K	Buy	+2	New	+$5.37K	﹤0.01%	1031

Other funds holding GNPX

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

NRG

Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return

Brown Brothers Harriman & Co's GNPX Position: Q3 2024 in Review

Brown Brothers Harriman & Co sold out of Genprex (GNPX) in Q3 2024, closing a stake of 2 shares — an estimated $4.71K sold.

Brown Brothers Harriman & Co first reported a position in GNPX in Q2 2024 and held it in 1 quarter. The position peaked at $4.71K in Q2 2024. 10 funds tracked by Wall St. Rank hold GNPX as of Q3 2024.

Brown Brothers Harriman & Co reported no remaining Genprex position as of Q3 2024 after selling out during the quarter.
Brown Brothers Harriman & Co sold 2 Genprex shares in Q3 2024, an estimated $4.71K.
Brown Brothers Harriman & Co first reported a position in Genprex in Q2 2024 and held it in 1 quarter.
Brown Brothers Harriman & Co's Genprex position peaked at $4.71K in Q2 2024.
10 funds tracked by Wall St. Rank held Genprex as of Q3 2024.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2024, filed 13 Nov 2024.